To overcome these problems, our studies must be complemented with additional phosphoproteomic, proteomic, and activity-based profiling analysis in the future to adequately identify the full spectrum of mechanisms by which RHO GTPase-regulated pathways impact cancer cell biology and pathophysiology. The gene discussed is RHO; the disease is cancer.